38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Protective Effects of Thalidomide on High-Glucose-Induced Podocyte Injury through In Vitro Modulation of Macrophage M1/M2 Differentiation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective. It has been shown that podocyte injury represents an important pathological basis that contributes to proteinuria and eventually leads to kidney failure. High glucose (HG) activates macrophage polarization, further exacerbating HG-induced podocyte injury. Our previous study on diabetic nephropathy rats indicated that thalidomide (Tha) has renoprotective properties. The present study explored the effects of Tha on mRNA and protein expressions of inducible nitric oxide synthase (iNOS), tumor necrosis factor- (TNF-) α, mannose receptor (CD206), and arginase- (Arg-) 1 in HG-activated macrophages. iNOS and TNF- α are established as markers of classically activated macrophage (M1). CD206 and Arg-1 are regarded as markers of alternatively activated macrophages (M2). During the experiment, the supernatants of (HG)-treated and (Tha)-treated macrophages, designated as (HG) MS and (Tha) MS, were simultaneously collected and processed. TNF- α and interleukin- (IL-) 1 β levels as well as protein expressions of nephrin and podocin in HG, (HG) MS, and (Tha) MS-cultured podocytes were evaluated. The results showed that compared to the 11.1 mM normal glucose (NG), the 33.3 mM HG-cultured RAW 264.7 cells exhibited upregulated iNOS and TNF- α mRNAs and protein expressions, and downregulated CD206 and Arg-1 expressions significantly ( p < 0.05). Tha 200  μg/ml suppressed iNOS and TNF- α, and promoted CD206 and Arg-1 expressions significantly compared to the HG group ( p < 0.05). Furthermore, (HG) MS-treated podocytes showed an increase in TNF- α and IL-1 β levels and a downregulation in nephrin and podocin expression significantly compared to NG-treated and HG-treated podocytes ( p < 0.05). The (Tha 200  μg/ml) MS group exhibited a decrease in TNF- α and IL-1 β level, and an upregulation in nephrin and podocin expressions significantly compared to the (HG) MS group ( p < 0.05). Our research confirmed that HG-activated macrophage differentiation aggravates HG-induced podocyte injury in vitro and the protective effects of Tha might be related to its actions on TNF- α and IL-1 β levels via its modulation on M1/M2 differentiation.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: not found
          • Article: not found

          Trends in Chronic Kidney Disease in China.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

            Thalidomide selectively inhibits the production of human monocyte tumor necrosis factor alpha (TNF-alpha) when these cells are triggered with lipopolysaccharide and other agonists in culture. 40% inhibition occurs at the clinically achievable dose of the drug of 1 micrograms/ml. In contrast, the amount of total protein and individual proteins labeled with [35S]methionine and expressed on SDS-PAGE are not influenced. The amounts of interleukin 1 beta (IL-1 beta), IL-6, and granulocyte/macrophage colony-stimulating factor produced by monocytes remain unaltered. The selectivity of this drug may be useful in determining the role of TNF-alpha in vivo and modulating its toxic effects in a clinical setting.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy

              Diabetic nephropathy (DN) together with glomerular hyperfiltration has been implicated in the development of diabetic microangiopathy in the initial stage of diabetic diseases. Increased amounts of urinary protein in DN may be associated with functional and morphological alterations of podocyte, mainly including podocyte hypertrophy, epithelial-mesenchymal transdifferentiation (EMT), podocyte detachment, and podocyte apoptosis. Accumulating studies have revealed that disruption in multiple renal signaling pathways had been critical in the progression of these pathological damages, such as adenosine monophosphate-activated kinase signaling pathways (AMPK), wnt/β-catenin signaling pathways, endoplasmic reticulum stress-related signaling pathways, mammalian target of rapamycin (mTOR)/autophagy pathway, and Rho GTPases. In this review, we highlight new molecular insights underlying podocyte injury in the progression of DN, which offer new therapeutic targets to develop important renoprotective treatments for DN over the next decade.
                Bookmark

                Author and article information

                Contributors
                Journal
                J Immunol Res
                J Immunol Res
                JIR
                Journal of Immunology Research
                Hindawi
                2314-8861
                2314-7156
                2020
                27 August 2020
                : 2020
                : 8263598
                Affiliations
                Department of Pharmacy, Shanxi Provincial People's Hospital of Shanxi Medical University, Taiyuan 030012, China
                Author notes

                Guest Editor: Charles Elias Assmann

                Author information
                https://orcid.org/0000-0001-6325-062X
                https://orcid.org/0000-0002-8082-4389
                Article
                10.1155/2020/8263598
                7474395
                d76a756f-6e43-4ce8-b57f-c99323c3c330
                Copyright © 2020 Hui Liao et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 21 April 2020
                : 25 June 2020
                : 11 July 2020
                Funding
                Funded by: Key R&D Project of Shanxi Province
                Award ID: 201903D421061
                Funded by: Shanxi Provincial People's Hospital
                Award ID: SZ2019007
                Award ID: SZ2019003
                Funded by: Basic Research Project of Shanxi Province
                Award ID: 201701D111001
                Categories
                Research Article

                Comments

                Comment on this article